###begin article-title 0
Monocyte urokinase-type plasminogen activator up-regulation reduces thrombus size in a model of venous thrombosis
###end article-title 0
###begin p 1
This document may be redistributed and reused, subject to .
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
Our previous studies showed that the direct injection of an adenovirus construct expressing urokinase-type plasminogen activator (uPA) into experimental venous thrombi significantly reduces thrombus weight. The systemic use of adenovirus vectors is limited by inherent hepatic tropism and inflammatory response. As macrophages are recruited into venous thrombi, it is reasonable to speculate that these cells could be used to target the adenovirus uPA (ad-uPA) gene construct to the thrombus. The aims of this study were to determine whether macrophages transduced with ad-uPA have increased fibrinolytic activity and whether systemic injection of transduced cells could be used to target uPA expression to the thrombus and reduce its size.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 127 132 <span type="species:ncbi:9606">human</span>
###xml 526 530 <span type="species:ncbi:10090">mice</span>
###xml 746 750 <span type="species:ncbi:10090">mice</span>
###xml 836 841 <span type="species:ncbi:9606">human</span>
The effect of up-regulating uPA was examined in an immortalized macrophage cell line (MM6) and macrophages differentiated from human blood monocyte-derived macrophages (HBMMs). Cells were infected with ad-uPA or blank control virus (ad-blank). Fibrinolytic mediator expression, cell viability, and cytokine expression were measured by activity assays and enzyme-linked immunosorbent assays. Monocyte migration was measured using a modified Boyden chamber assay. A model of venous thrombosis was developed and characterized in mice with severe combined immunodeficiency (SCID). This model was used to study whether systemically administered macrophages over-expressing uPA reduced thrombus size. Uptake of HBMMs into the thrombus induced in these mice was confirmed by a combination of PKH2-labeled cell tracking and colocalization with human leukocyte antigen (HLA) by immunohistology.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 103 104 103 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 140 141 140 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 203 204 203 204 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 310 311 310 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 335 336 335 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 562 563 562 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 596 597 596 597 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 885 886 885 886 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 921 922 921 922 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 647 652 <span type="species:ncbi:9606">Human</span>
###xml 685 690 <span type="species:ncbi:10090">mouse</span>
Compared with ad-blank, treated HBMMs transduction with ad-uPA increased uPA production by >1000-fold (P = .003), uPA activity by 150-fold (P = .0001), and soluble uPA receptor (uPAR) by almost twofold (P = .043). Expression of plasminogen activator inhibitor (PAI-1) and PAI-2 was decreased by about twofold (P = .011) and threefold (P = .005), respectively. Up-regulation of uPA had no effect on cell viability or inflammatory cytokine production compared with ad-blank or untreated cells. Ad-uPA transduction increased the migration rate of HBMMs (about 20%, P = .03) and MM6 cells (>twofold, P = .005) compared with ad-blank treated controls. Human macrophage recruitment into the mouse thrombus was confirmed by the colocalization of HLA with the PKH2-marked cells. Systemic injection of uPA-up-regulated HBMMs reduced thrombus weight by approximately 20% compared with ad-blank (P = .038) or sham-treated controls (P = .0028).
###end p 7
###begin title 8
Conclusion
###end title 8
###begin p 9
Transduction of HBBM with ad-uPA increases their fibrinolytic activity. Systemic administration of uPA up-regulated HBBMs reduced thrombus size in an experimental model of venous thrombosis. Alternative methods of delivering fibrinolytic agents are worth exploring.
###end p 9
###begin title 10
Clinical Relevance
###end title 10
###begin p 11
###xml 107 115 <span type="species:ncbi:9606">patients</span>
The use of thrombolysis in the treatment of acute iliofemoral deep vein thrombosis is not suitable for all patients. Our previous studies have shown that direct injection of an adenovirus construct expressing urokinase plasminogen activator (uPA) into experimental venous thrombi significantly reduced thrombus weight. The systemic use of adenovirus vectors is, however, limited by both their inherent hepatic tropism, which precludes targeted delivery to disease sites, and by the associated host inflammatory response. As macrophages are recruited into venous thrombi, these cells could be used to target uPA gene constructs to the thrombus after systemic administration.
###end p 11
###begin p 12
###xml 247 248 247 248 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 247 248 247 248 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib1" ref-type="bibr"><sup>1</sup></xref>
###xml 326 327 326 327 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 326 327 326 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib2" ref-type="bibr"><sup>2</sup></xref>
###xml 249 257 <span type="species:ncbi:9606">Patients</span>
The changes that lead to post-thrombotic syndrome are caused by a combination of valvular damage and persistent venous outflow restriction. Rapid recanalization of veins preserves valve integrity and is associated with a lower incidence of reflux.1 Patients with shorter recanalization times have an improved clinical outcome.2 It is therefore reasonable to expect that enhancing thrombus resolution may reduce the incidence of post-thrombotic complications.
###end p 12
###begin p 13
###xml 169 170 169 170 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sup>
###xml 169 170 169 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib3" ref-type="bibr"><sup>3</sup></xref>
###xml 393 394 393 394 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sup>
###xml 393 394 393 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib4" ref-type="bibr"><sup>4</sup></xref>
###xml 799 800 799 800 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 799 800 799 800 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib5" ref-type="bibr"><sup>5</sup></xref>
###xml 337 345 <span type="species:ncbi:9606">patients</span>
Venous thrombosis is usually treated by anticoagulation, which reduces the risk of pulmonary embolism, prevents thrombus propagation, and allows slow natural resolution.3 Anticoagulants do not, however, promote natural resolution and can cause bleeding complications. Thrombolytic agents and thrombectomy remove thrombus rapidly in some patients who are treated early but their use is limited.4 Novel strategies that replace or augment anticoagulation and hasten thrombus resolution without the risk of hemorrhage are therefore attractive. Natural thrombus resolution is regulated by an inflammatory response involving the recruitment of neutrophils and monocytes, followed by endothelial cells and myofibroblasts, leading to thrombus organization, contraction, and recanalization of the vein lumen.5
###end p 13
###begin p 14
###xml 174 175 174 175 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 174 175 174 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib6" ref-type="bibr"><sup>6</sup></xref>
###xml 235 236 235 236 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 235 236 235 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib7" ref-type="bibr"><sup>7</sup></xref>
###xml 327 328 327 328 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">8</sup>
###xml 327 328 327 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib8" ref-type="bibr"><sup>8</sup></xref>
###xml 441 442 441 442 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">9</sup>
###xml 441 442 441 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib9" ref-type="bibr"><sup>9</sup></xref>
There is a progressive increase in plasminogen activator (PA) activity within the thrombus as organization proceeds that appears to be associated with the influx of monocytes6 that are recruited into the thrombus in a temporal pattern.7 The fibrinolytic system is an important mediator of cell migration and tissue remodelling.8 Net fibrinolytic activity is the product of the relative abundance of PAs and their inhibitors, PAI-1 and PAI-2.9
###end p 14
###begin p 15
###xml 192 194 192 194 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sup>
###xml 192 194 192 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib10" ref-type="bibr"><sup>10</sup></xref>
Deletion of the gene encoding the urokinase-type plasminogen activator (uPA) prevents thrombus resolution, and this is associated with a marked reduction in monocyte ingress into the thrombus.10 These findings have led to the hypothesis that monocyte recruitment, regulated through the expression of uPA, is an essential mechanism in thrombus resolution.
###end p 15
###begin p 16
###xml 139 141 139 141 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sup>
###xml 139 141 139 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib11" ref-type="bibr"><sup>11</sup></xref>
###xml 349 351 349 351 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sup>
###xml 349 351 349 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib12" ref-type="bibr"><sup>12</sup></xref>
Direct injection of an adenovirus construct expressing uPA (ad-uPA) into experimental venous thrombi significantly reduces thrombus weight.11 The systemic use of adenovirus vectors, however, is limited by their inherent hepatic tropism, which precludes targeted delivery to alternative organs or disease sites, and by the host inflammatory response.12 As monocytes are recruited into venous thrombi, it would be reasonable to speculate that these cells could be used to target the ad-uPA gene construct to the thrombus after systemic administration. The aims of this study were therefore to determine whether monocytes transduced with ad-uPA have increased fibrinolytic activity and whether systemic injection of transduced cells could be used to target uPA expression to the thrombus and reduce its size.
###end p 16
###begin title 17
Materials and methods
###end title 17
###begin p 18
###xml 149 151 149 151 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sup>
###xml 149 151 149 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib13" ref-type="bibr"><sup>13</sup></xref>
###xml 131 136 <span type="species:ncbi:9606">human</span>
###xml 224 229 <span type="species:ncbi:9606">human</span>
Permission to conduct these studies was obtained from St Thomas' Hospital Ethics Committee. Serotype-5 adenoviral vectors encoding human uPA (ad-uPA)13 and an empty cassette (ad-blank) were used. Adenovirus was amplified in human embryonic kidney cells (HEK-293), and purified and titered using the AdenoX system (Becton Dickinson, Franklin Lakes, NJ).
###end p 18
###begin title 19
###xml 16 21 <span type="species:ncbi:9606">human</span>
Transduction of human blood monocyte-derived macrophages
###end title 19
###begin p 20
###xml 108 110 108 110 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">14</sup>
###xml 108 110 108 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib14" ref-type="bibr"><sup>14</sup></xref>
###xml 372 374 372 374 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">15</sup>
###xml 372 374 372 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib15" ref-type="bibr"><sup>15</sup></xref>
###xml 240 244 <span type="species:ncbi:9913">calf</span>
Pure (>90%) monocyte preparations were isolated from blood using Optiprep (Axis-Shield, Cambridgeshire, UK).14 Isolated cells were resuspended in Roswell Park Memorial Institute media (Sigma Aldrich, Dorset, UK) supplemented with 10% fetal calf serum (Life Technologies, Paisley, UK) and 2 mM glutamine (Sigma). Monocytes/macrophages are resistant to adenovirus infection.15 Cells were therefore cultured for 72 hours with 100-ng/mL monocyte colony-stimulating factor (MCSF; R&D Systems, Abingdon, UK) to up-regulate integrins, which facilitate adenoviral infection. Cells were treated with the adenovirus or culture media alone (baseline control) at a multiplicity of infection (MOI) of up to 2500 and harvested after 4 days. Cell viability was assessed by measuring lactate dehydrogenase (LDH; Promega, Southampton, UK) and caspase-3 activity (Sigma) in conditioned media.
###end p 20
###begin title 21
###xml 16 21 <span type="species:ncbi:9606">human</span>
Confirmation of human blood monocyte-derived macrophages transduction
###end title 21
###begin p 22
###xml 74 75 74 75 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8226;</label>
###xml 75 100 75 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">uPA fibrin plate analysis</italic>
###xml 75 427 75 420 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="23"><italic>uPA fibrin plate analysis</italic>: A fibrin gel was formed using fibrinogen (0.4%, Sigma), agarose (0.15%, Sigma), and lys-plasminogen (25 &#956;g/mL) in phosphate-buffered saline (pH 7.4; Sigma). Fibrin cross-linkage was induced by the addition of thrombin (5 IU/mL). Conditioned media and active uPA standards were added and incubated for 12 hours at 37&#176;C.</p>
###xml 74 427 74 420 <list-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><label>&#8226;</label><p textid="23"><italic>uPA fibrin plate analysis</italic>: A fibrin gel was formed using fibrinogen (0.4%, Sigma), agarose (0.15%, Sigma), and lys-plasminogen (25 &#956;g/mL) in phosphate-buffered saline (pH 7.4; Sigma). Fibrin cross-linkage was induced by the addition of thrombin (5 IU/mL). Conditioned media and active uPA standards were added and incubated for 12 hours at 37&#176;C.</p></list-item>
###xml 427 428 420 421 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8226;</label>
###xml 428 463 421 456 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">uPA S2444 substrate activity assay:</italic>
###xml 529 531 522 524 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">16</sup>
###xml 529 531 522 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib16" ref-type="bibr"><sup>16</sup></xref>
###xml 428 531 421 524 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="24"><italic>uPA S2444 substrate activity assay:</italic> Urokinase (uPA) activity was measured using a colorimetric assay.<xref rid="bib16" ref-type="bibr"><sup>16</sup></xref></p>
###xml 427 531 420 524 <list-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><label>&#8226;</label><p textid="24"><italic>uPA S2444 substrate activity assay:</italic> Urokinase (uPA) activity was measured using a colorimetric assay.<xref rid="bib16" ref-type="bibr"><sup>16</sup></xref></p></list-item>
###xml 74 531 74 524 <list xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" list-type="simple"><list-item><label>&#8226;</label><p textid="23"><italic>uPA fibrin plate analysis</italic>: A fibrin gel was formed using fibrinogen (0.4%, Sigma), agarose (0.15%, Sigma), and lys-plasminogen (25 &#956;g/mL) in phosphate-buffered saline (pH 7.4; Sigma). Fibrin cross-linkage was induced by the addition of thrombin (5 IU/mL). Conditioned media and active uPA standards were added and incubated for 12 hours at 37&#176;C.</p></list-item><list-item><label>&#8226;</label><p textid="24"><italic>uPA S2444 substrate activity assay:</italic> Urokinase (uPA) activity was measured using a colorimetric assay.<xref rid="bib16" ref-type="bibr"><sup>16</sup></xref></p></list-item></list>
Urokinase upregulation was confirmed before use in all studies as follows:*uPA fibrin plate analysis: A fibrin gel was formed using fibrinogen (0.4%, Sigma), agarose (0.15%, Sigma), and lys-plasminogen (25 mug/mL) in phosphate-buffered saline (pH 7.4; Sigma). Fibrin cross-linkage was induced by the addition of thrombin (5 IU/mL). Conditioned media and active uPA standards were added and incubated for 12 hours at 37degreesC.*uPA S2444 substrate activity assay: Urokinase (uPA) activity was measured using a colorimetric assay.16
###end p 22
###begin p 23
###xml 0 25 0 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">uPA fibrin plate analysis</italic>
uPA fibrin plate analysis: A fibrin gel was formed using fibrinogen (0.4%, Sigma), agarose (0.15%, Sigma), and lys-plasminogen (25 mug/mL) in phosphate-buffered saline (pH 7.4; Sigma). Fibrin cross-linkage was induced by the addition of thrombin (5 IU/mL). Conditioned media and active uPA standards were added and incubated for 12 hours at 37degreesC.
###end p 23
###begin p 24
###xml 0 35 0 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">uPA S2444 substrate activity assay:</italic>
###xml 101 103 101 103 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">16</sup>
###xml 101 103 101 103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib16" ref-type="bibr"><sup>16</sup></xref>
uPA S2444 substrate activity assay: Urokinase (uPA) activity was measured using a colorimetric assay.16
###end p 24
###begin title 25
Fibrinolytic activity and inflammatory mediator expression after adenovirus transduction
###end title 25
###begin p 26
###xml 275 277 275 277 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">16</sup>
###xml 275 277 275 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib16" ref-type="bibr"><sup>16</sup></xref>
###xml 324 326 324 326 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">17</sup>
###xml 324 326 324 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib17" ref-type="bibr"><sup>17</sup></xref>
###xml 361 363 361 363 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">18</sup>
###xml 361 363 361 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib18" ref-type="bibr"><sup>18</sup></xref>
###xml 370 372 370 372 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">19</sup>
###xml 370 372 370 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib19" ref-type="bibr"><sup>19</sup></xref>
###xml 183 188 <span type="species:ncbi:9606">human</span>
Monocytes were isolated from 12 donors and transfected with 1000 MOI of ad-uPA, ad-blank, or carrier alone (baseline control). Levels of uPA activity and uPA antigen were measured in human blood monocyte-derived macrophages (HBMM)-conditioned media using a colorimetric assay16 and enzyme-linked immunosorbent assay (ELISA),17 respectively. The levels of PAI-1,18 PAI-2,19 soluble uPA receptor (uPAR, R&D Systems), tissue plasminogen activator (tPA; gift, Prof. P. J. Declerck, Leuven, Belgium), and monocyte chemotactic protein-1 (MCP-1, R&D Systems) were measured by ELISA. Tumour necrosis factor-alpha (TNF-alpha), regulated upon activation normal T-cell expressed and secreted (RANTES), interferon-gamma (IFN-gamma), interleukin-1alpha (IL-1alpha), IL-1beta, IL-4, IL-6, IL-8, IL-10, and granulocyte macrophage-colony stimulating factor (GM-CSF) were measured using the Beadmaster system (Upstate, USA, Millipore, Billerica, Mass).
###end p 26
###begin title 27
Ad-uPA transduction and monocyte migration in vitro
###end title 27
###begin p 28
###xml 219 221 219 221 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">20</sup>
###xml 219 221 219 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib20" ref-type="bibr"><sup>20</sup></xref>
A macrophage cell line, MM6 (gift, Professor Ziegler-Heitbrock, Munich, Germany), and HBMMs were transfected with 1000 MOI of ad-uPA or ad-blank as described. Cell migration was assessed using a modified Boyden chamber.20 Cells were fluorescently labeled with Calcein AM (Invitrogen, Paisley, UK).
###end p 28
###begin p 29
###xml 164 165 163 164 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
Filter inserts (3-mum pore size, Fluoroblok; BD Biosciences, Becton Dickinson, Franklin Lakes, NJ) were coated in fibrin gel to a depth of 1 mm. Macrophages (5 x 105 cells) were added to the upper chamber, and MCP-1 (300 ng/mL, R&D Systems) or carrier was added to the lower chamber. Fluorescence was measured over 150 minutes (VictorLight; Perkin-Elmer, Salem, Mass).
###end p 29
###begin p 30
Experiments were performed in quintuplicate with MM6 cells and in triplicate with HBMMs. The data were expressed as the percentage of maximal fluorescence obtained from the total number of labeled cells used.
###end p 30
###begin title 31
###xml 33 38 <span type="species:ncbi:10090">mouse</span>
Severe combined immunodeficiency mouse model of venous thrombosis
###end title 31
###begin p 32
###xml 208 213 208 213 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10,11</sup>
###xml 208 213 208 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib10 bib11" ref-type="bibr"><sup>10,11</sup></xref>
###xml 466 468 464 466 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sup>
###xml 466 468 464 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib10" ref-type="bibr"><sup>10</sup></xref>
###xml 585 587 583 585 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">21</sup>
###xml 585 587 583 585 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib21" ref-type="bibr"><sup>21</sup></xref>
###xml 156 160 <span type="species:ncbi:10090">mice</span>
UK Home Office approval was obtained for all animal procedures. Thrombosis was induced in the inferior vena cava of severe combined immunodeficiency (SCID) mice using reduced flow and endothelial disturbance.10,11 Thrombi were harvested at 1, 7, 14 and 21 days after induction. Paraffin sections (5 mum) were taken at 300-mum intervals throughout the whole length of the thrombus. The area of thrombus over a defined length gives an approximation of thrombus volume.10 Thrombus and recanalization areas were measured in sections stained with hematoxylin and eosin using image analysis.21
###end p 32
###begin p 33
Neutrophil ingress (identified by nuclear morphology) was assessed in hematoxylin and eosin sections taken from 1-day-old thrombi. Lymphocytes were stained with anti-CD3, a T-cell marker, and anti-CD79a, a B-cell marker (both Abcam, Cambridge, UK).
###end p 33
###begin p 34
###xml 41 42 41 42 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 41 42 41 42 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib7" ref-type="bibr"><sup>7</sup></xref>
###xml 111 116 <span type="species:ncbi:10090">mouse</span>
Monocyte ingress occurs at a later stage.7 Sections from 7- and 14-day thrombi were therefore stained with the mouse monocyte marker MAC3 (BD Pharminogen, Becton Dickinson, Franklin Lakes, NJ). Primary antibody binding was located using biotinylated secondary antibodies and the ABC-peroxidase complex (Vector Laboratories, Peterborough, UK). Matched isotype or polyclonal immunoglobulin from the appropriate species acted as controls. Twenty sections of each thrombus were evaluated for each stain or control. Staining was quantified by image analysis and calculated as a mean percentage of the total area.
###end p 34
###begin title 35
###xml 37 41 <span type="species:ncbi:10090">mice</span>
Tracking of HBMMs injected into SCID mice
###end title 35
###begin p 36
###xml 90 92 90 92 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">22</sup>
###xml 90 92 90 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib22" ref-type="bibr"><sup>22</sup></xref>
###xml 116 117 116 117 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 164 169 <span type="species:ncbi:10090">mouse</span>
###xml 337 342 <span type="species:ncbi:9606">human</span>
HBMMs were isolated and labeled with PKH2 fluorescent cell marker as previously described.22 Labeled cells (6.5 x 105) were injected into the tail vein of the SCID mouse 2 hours before thrombus formation. The thrombi were removed after 7 days. PKH2 green fluorescence was colocalized with the binding of a red fluorescently labeled anti-human leukocyte antigen (HLA) antibody (Serotec, Kidlington, UK). Primary antibody was detected with an antimouse Alexa 568 conjugated secondary antibody (Cambridge Biosciences, Cambridge, UK). An isotype-matched antibody was used as a negative control.
###end p 36
###begin title 37
The effect of uPA up-regulation in HBMMs on thrombus resolution
###end title 37
###begin p 38
###xml 13 14 13 14 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 501 503 501 503 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">23</sup>
###xml 501 503 501 503 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib23" ref-type="bibr"><sup>23</sup></xref>
###xml 165 169 <span type="species:ncbi:10090">mice</span>
HBMMs (1 x 106 cells) were transfected with 2500 MOI of ad-uPA or ad-blank and injected 2 hours before thrombus formation into the tail vein of two cohorts of eight mice. A third cohort of eight animals was injected with carrier containing no cells. The thrombi were harvested 7 days after induction, in a blinded manner. At 7 days, the model thrombus in untreated controls is still occlusive but beginning to organize; therefore, any effect of treatment would be expected to be maximal at this point.23
###end p 38
###begin title 39
Statistical analysis
###end title 39
###begin p 40
###xml 219 220 217 218 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 301 302 299 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U</italic>
Values were expressed as mean +/- standard error (SEM). Two-way analysis of variance (ANOVA) was used to compare the temporal changes in thrombus resolution in the SCID model and wild-type controls. Paired and unpaired t tests were used for comparisons of parametric data and Wilcoxon or Mann Whitney U tests were applied to nonparametric data.
###end p 40
###begin title 41
Results
###end title 41
###begin title 42
HBMM fibrinolytic mediator production and cytokine response after ad-uPA transduction
###end title 42
###begin p 43
###xml 71 72 71 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 123 130 123 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="tbl1" ref-type="table">Table I</xref>
###xml 239 240 239 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 249 256 249 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="tbl1" ref-type="table">Table I</xref>
###xml 400 401 400 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 457 458 457 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 525 526 525 526 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 713 720 713 720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="tbl1" ref-type="table">Table I</xref>
Ad-uPA transduction increased HBMM fibrinolytic activity by >150-fold (P = .0001) compared with ad-blank-treated controls (Table I). Production of uPA antigen was increased from the lower limit of detection of the uPA ELISA by >1000-fold (P = .003, Table I). No tPA antigen or activity could be measured in treated HBMMs. Up-regulation of uPA resulted in a 1.6-fold increase in HBMM uPAR production (P = .043); almost 1.6-fold decrease in PAI-1 production (P = .011); and a greater than twofold decrease in PAI-2 production (P = .005) compared with ad-blank controls. No significant difference between ad-blank and baseline (carrier alone) control groups was shown for any of the fibrinolytic mediators measured (Table I).
###end p 43
###begin p 44
###xml 217 225 213 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="tbl2" ref-type="table">Table II</xref>
Five of 10 cytokines analyzed were detectable (IL-8, IL-6, IFN-gamma, RANTES, GM-CSF), and the expression of these cytokines was not significantly different between baseline and cells treated with ad-uPA or ad-blank (Table II). Levels of IL-1alpha, IL- 1beta, TNF-alpha, IL-4, and IL-10 could not be measured. LDH release and caspase-3 activity could not be measured in untreated (baseline) cells or cells treated with ad-uPA.
###end p 44
###begin title 45
Effect of monocyte uPA up-regulation on in vitro MM6 and HBMM migration
###end title 45
###begin p 46
###xml 168 169 164 165 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 179 184 175 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig1" ref-type="fig">Fig 1</xref>
###xml 362 363 354 355 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 371 376 363 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig2" ref-type="fig">Fig 2</xref>
Transduction with ad-uPA resulted in a more rapid migration of MM6 cells across fibrin-coated filters (11% +/- 1.4%) compared with ad-blank-treated cells (5% +/- 0.6%, P = 0.005, Fig 1). Treatment with ad-uPA also resulted in the accelerated movement of HBMMs cells across fibrin-coated filters (70% +/- 8.9%) compared with ad-blank-treated cells (54% +/- 9.8%, P = .03, Fig 2).
###end p 46
###begin title 47
###xml 48 52 <span type="species:ncbi:10090">mice</span>
Characterization of thrombus resolution in SCID mice
###end title 47
###begin p 48
###xml 215 216 211 212 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 258 259 250 251 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 299 300 287 288 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 344 345 328 329 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 362 363 346 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 676 677 656 657 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 856 857 836 837 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 48 52 <span type="species:ncbi:10090">mice</span>
###xml 138 142 <span type="species:ncbi:10090">mice</span>
###xml 590 594 <span type="species:ncbi:10090">mice</span>
Laminar thrombi were successfully formed in all mice with no complications. There was no difference in the thrombus size between the SCID mice and their wild-type controls at 24 hours (11.4 +/- 0.8 vs 12.3 +/- 1.6mm2), 1 week (10.2 +/- 1.7 vs 12.9 +/- 1.3 mm2), 2 weeks (2.5 +/-0.6 vs 5.5 +/- 2.3 mm2), or 3 weeks (1.7 +/- 0.3 vs 1.6 +/- 0.7 mm2; two-way ANOVA, P > .1, n = 8/group); ad hoc post-testing also showed no difference in thrombus size at any time interval. The number and distribution of neutrophils in the infiltrate that occurred during thrombogenesis was similar in the SCID mice (8.4% +/- 0.8% of thrombus area compared with 7.1% +/- 1% in wild type controls, P > .1, n = 8/group). There was also no difference in the area of thrombus recanalization or the number of infiltrating monocytes found in the two groups during resolution (ANOVA, P > 0.1, n = 8/group).
###end p 48
###begin p 49
###xml 161 162 157 158 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 205 206 197 198 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 252 253 240 241 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 270 271 258 259 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
No difference was found in the speed and size of vein lumen recanalization between the SCID and their wild-type controls at 1 week (3.5 +/- 0.5 vs 5.4 +/- 1.0 mm2), 2 weeks (11.4 +/- 1.3 vs 11.3 +/- 1.4 mm2), or 3 weeks (22.9 +/- 1.8 vs 21.9 +/- 1.7 mm2; two-way ANOVA, P > 0.1).
###end p 49
###begin title 50
Tracking of injected HBMMs
###end title 50
###begin p 51
###xml 268 273 268 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig3" ref-type="fig">Fig 3</xref>
More than 90% of HBMMs were labeled with PKH2. Fluorescently labeled (PKH2) HBMMs were present in the thrombus at 7 days after intravenous injection. There was negligible fluorescence in the vein wall at this time. The PKH2-labeled cells costained positively for HLA (Fig 3).
###end p 51
###begin title 52
Effect of monocyte uPA up-regulation on thrombus resolution
###end title 52
###begin p 53
###xml 331 332 327 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 408 409 402 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 419 424 413 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="fig4" ref-type="fig">Fig 4</xref>
No evidence of any immune rejection was noted, and animals appeared to be healthy for the duration of the study. No pathologic bleeding or premature deaths occurred. Systemic injection of uPA-upregulated HBMMs reduced thrombus weight at 7 days by about 20% (9.0 +/- 0.52 mg) compared with ad-blank-treated HBMMs (11.0 +/- 0.74 mg, P = .038) and control animals injected with carrier alone (13.3 +/- 1.08 mg, P = .0028, Fig 4).
###end p 53
###begin title 54
Discussion
###end title 54
###begin p 55
###xml 621 623 621 623 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sup>
###xml 621 623 621 623 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib11" ref-type="bibr"><sup>11</sup></xref>
###xml 721 723 721 723 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sup>
###xml 721 723 721 723 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib13" ref-type="bibr"><sup>13</sup></xref>
To our knowledge, this is the first report to show that adenovirus-mediated up-regulation of uPA in monocytic cells reduces the weight of experimentally induced venous thrombi. Transduction of HBMMs with ad-uPA resulted in >150-fold increase in uPA-mediated fibrinolytic activity compared with ad-blank-transfected cells, without affecting their viability or inflammatory responses in vitro. The increased uPA activity was observed 4 days after transduction in vitro. We have previously shown that direct injection of the construct used in this study results in increased uPA activity in the thrombus for at least 7 days,11 while others have reported that this construct expresses active uPA for at least 14 days in vivo.13
###end p 55
###begin p 56
###xml 529 531 529 531 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">24</sup>
###xml 529 531 529 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib24" ref-type="bibr"><sup>24</sup></xref>
###xml 1049 1051 1049 1051 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">25</sup>
###xml 1049 1051 1049 1051 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib25" ref-type="bibr"><sup>25</sup></xref>
###xml 1161 1163 1161 1163 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">25</sup>
###xml 1161 1163 1161 1163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib25" ref-type="bibr"><sup>25</sup></xref>
The increased fibrinolytic activity of ad-uPA up-regulated HBMMs was also associated with a modest but significant rise in the expression of uPAR and a reduction in PAI-1 and PAI-2 protein levels. The higher levels of soluble uPAR produced by the cells treated with ad-uPA may have reflected the cleavage of uPAR at the cell surface by the increased amounts of uPA expressed. Urokinase mediates the cleavage of uPAR as part of a negative feedback mechanism to regulate activation of plasminogen on the surface of monocytic cells.24 The reduced levels of PAI-1 and PAI-2 cannot be explained by the inability of the ELISAs to discriminate between PAI:uPA complexes, because there was no difference in the ELISA signal generated after the addition of excess PAI to a standard amount of uPA compared with uPA alone (data not shown). The reduced expression of both PAI-1 and PAI-2 after transduction with the ad-uPA construct may have been the result of their internalization by endocytosis after inhibition of uPA:uPAR complexes by either of these PAIs.25 Levels of the uPAR would be less affected by this process as it is subsequently recycled to the cell surface.25
###end p 56
###begin p 57
###xml 192 194 192 194 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">26</sup>
###xml 192 194 192 194 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib26" ref-type="bibr"><sup>26</sup></xref>
###xml 298 300 298 300 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">27</sup>
###xml 298 300 298 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib27" ref-type="bibr"><sup>27</sup></xref>
###xml 161 166 <span type="species:ncbi:9606">human</span>
Treatment of isolated HBMMs with ad-uPA did not appear to induce an inflammatory response. This finding is similar to that obtained after ad-tPA transduction of human mononuclear cell isolates26 but contrasts with studies on the effect of general adenoviral infection on mononuclear cell responses.27 It is difficult, however, to compare these studies because there are a number of differences in the methods used, including different isolation procedures and cell pre-treatments that may affect the expression of inflammatory mediators by macrophages. Some of the cytokines assessed in this study could not be measured because they fell below the sensitivity of their respective assays. It is possible that there were minor differences between treatments that we could not detect. No difference was found between ad-uPA, ad-blank, or uninfected cells in the levels of inflammatory cytokines that were measurable.
###end p 57
###begin p 58
###xml 88 93 88 93 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10,11</sup>
###xml 88 93 88 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib10 bib11" ref-type="bibr"><sup>10,11</sup></xref>
###xml 555 557 555 557 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">28</sup>
###xml 555 557 555 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib28" ref-type="bibr"><sup>28</sup></xref>
###xml 671 673 671 673 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">29</sup>
###xml 671 673 671 673 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib29" ref-type="bibr"><sup>29</sup></xref>
###xml 703 705 703 705 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">30</sup>
###xml 703 705 703 705 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib30" ref-type="bibr"><sup>30</sup></xref>
###xml 745 747 745 747 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">28</sup>
###xml 745 747 745 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib28" ref-type="bibr"><sup>28</sup></xref>
###xml 43 48 <span type="species:ncbi:10090">mouse</span>
###xml 75 80 <span type="species:ncbi:10090">mouse</span>
###xml 602 606 <span type="species:ncbi:10090">mice</span>
The model of venous thrombosis in the SCID mouse was based on our previous mouse models.10,11 Thrombus formation was highly reproducible, whereas the pattern of resolution was similar to that seen in wild-type controls, suggesting that lymphocytes do not participate in thrombus organization. The absence of lymphocytes did not appear to affect the number and distribution of other leukocytes found within the resolving thrombi. Neutrophils, which are the most common type of inflammatory cells found in the thrombus at an early stage after its formation,28 were present in similar numbers in the SCID mice and their wild-type controls. Neutrophils have both fibrinolytic29 and antifibrinolytic activity30 that appears to regulate thrombus size.28
###end p 58
###begin p 59
###xml 136 140 <span type="species:ncbi:10090">mice</span>
###xml 209 214 <span type="species:ncbi:9606">human</span>
A similar temporal and spatial distribution of monocyte recruitment and revascularization was also seen in the thrombi produced in SCID mice compared with their wild-type controls. The model allowed us to use human monocytes, which are more easily isolated, in larger numbers and with greater purity than rodent monocytes. This negated the use of large numbers of donor animals.
###end p 59
###begin p 60
###xml 128 130 128 130 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">13</sup>
###xml 128 130 128 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib13" ref-type="bibr"><sup>13</sup></xref>
###xml 113 118 <span type="species:ncbi:9606">human</span>
###xml 176 181 <span type="species:ncbi:9606">human</span>
###xml 199 204 <span type="species:ncbi:10090">mouse</span>
###xml 257 262 <span type="species:ncbi:9606">human</span>
###xml 304 310 <span type="species:ncbi:10090">murine</span>
###xml 335 341 <span type="species:ncbi:10090">murine</span>
###xml 561 567 <span type="species:ncbi:10090">murine</span>
###xml 596 602 <span type="species:ncbi:10090">murine</span>
Because the binding of uPA to its receptor is species specific, it was necessary to transduce the HBMMs with the human uPA gene.13 A weakness in this approach is that although human uPA can activate mouse plasminogen, it does this with less efficiency than human plasminogen (data not shown). The use of murine cells up-regulated with murine uPA was, however, precluded because the isolation of pure populations of these cells in sufficient numbers was not possible. It is conceivable, however, that a larger effect on thrombus size might have been achieved if murine macrophages upregulated for murine uPA had been used.
###end p 60
###begin p 61
###xml 123 125 123 125 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">31</sup>
###xml 123 125 123 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib31" ref-type="bibr"><sup>31</sup></xref>
###xml 278 282 278 282 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7,32</sup>
###xml 278 282 278 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib7 bib32" ref-type="bibr"><sup>7,32</sup></xref>
###xml 401 402 401 402 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7</sup>
###xml 401 402 401 402 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib7" ref-type="bibr"><sup>7</sup></xref>
###xml 459 464 <span type="species:ncbi:9606">human</span>
We have previously demonstrated that direct injection of macrophages into the thrombus significantly reduces thrombus size.31 These cells may stimulate resolution by expressing a variety of enzymes, growth, and chemotactic factors that stimulate organization and recanalization.7,32 Our previous work has shown that systemically injected rodent mononuclear cells are recruited into resolving thrombus.7 This study provides evidence that systemically injected human monocytes (HBMMs) are also recruited into the thrombus and that up-regulating uPA expression in these cells results in enhanced resolution. There are several plausible explanations for this effect:
###end p 61
###begin p 62
###xml 256 258 256 258 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">33</sup>
###xml 256 258 256 258 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib33" ref-type="bibr"><sup>33</sup></xref>
First, uPA accelerated monocyte migration and delivered fibrinolytically active monocytes much earlier to the thrombus. The in vitro studies showed a faster migration rate for both HBMMs and MM6 cells transfected with ad-uPA, confirming the work of others.33
###end p 62
###begin p 63
###xml 164 172 164 172 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10,33,34</sup>
###xml 164 172 164 172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib10 bib33 bib34" ref-type="bibr"><sup>10,33,34</sup></xref>
###xml 265 267 265 267 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">10</sup>
###xml 265 267 265 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib10" ref-type="bibr"><sup>10</sup></xref>
###xml 403 405 403 405 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">34</sup>
###xml 403 405 403 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib34" ref-type="bibr"><sup>34</sup></xref>
###xml 593 595 593 595 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">35</sup>
###xml 593 595 593 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib35" ref-type="bibr"><sup>35</sup></xref>
###xml 173 177 <span type="species:ncbi:10090">Mice</span>
Urokinase has a well-documented action on surface proteolysis, cell adhesion, chemotaxis, and migration and these effects have been noted both in vitro and in vivo.10,33,34 Mice lacking the uPA gene fail to recruit cells (monocytes in particular) into the thrombus.10 Urokinase-dependent conformational change in uPAR mediates cytoskeletal changes, activation of kinases, and directional cell migration.34 Urokinase also generates plasmin by cleaving the proenzyme plasminogen. Plasmin is not only fibrinolytic but also activates other proteases that are crucial for cell migration in tissues.35
###end p 63
###begin p 64
Reliable quantification of the numbers of HBMMs recruited was, however, difficult because of the background fluorescence associated with this label. Attempts at quantifying HBMM numbers using reverse transcription-polymerase chain reaction were not successful. Better methods of tracking injected monocytes using reporter gene technology in combination with imaging methods such as single photon emission computed tomography (SPECT/CT) or micro-PET would allow a sensitive, noninvasive (longitudinal), quantitative tracking of injected ad-uPA-transduced monocyte recruitment during resolution.
###end p 64
###begin p 65
###xml 359 361 359 361 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sup>
###xml 359 361 359 361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib11" ref-type="bibr"><sup>11</sup></xref>
Secondly, these cells may have promoted resolution by enhanced fibrinolysis mediated by the extra uPA generated within the thrombus. This is in keeping with our previous work showing that the induction of picogram quantities of uPA activity within the thrombus (generated from direct ad-uPA injection) is sufficient to increase the resolution of the thrombus.11
###end p 65
###begin p 66
Thirdly, it is also possible that ad-uPA-transduced monocytes accelerated resolution through other mechanisms that could include increasing endogenous monocyte influx by releasing chemotactic cytokines at an early stage in resolution.
###end p 66
###begin p 67
The development of methods capable of quantitatively tracking both endogenous and exogenously administered monocytes would help to define how these cells exert their effect on thrombus resolution.
###end p 67
###begin p 68
###xml 99 101 99 101 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">36</sup>
###xml 99 101 99 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib36" ref-type="bibr"><sup>36</sup></xref>
###xml 437 439 437 439 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">12</sup>
###xml 437 439 437 439 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib12" ref-type="bibr"><sup>12</sup></xref>
###xml 599 601 599 601 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">37</sup>
###xml 599 601 599 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib37" ref-type="bibr"><sup>37</sup></xref>
###xml 54 60 <span type="species:ncbi:9606">humans</span>
Altered macrophages have been used therapeutically in humans for the treatment of malignant disease36 and might also be used as gene delivery vehicles because they have a natural tendency to migrate to the site of disease, such as the thrombus. Using cells that have been altered by ex vivo manipulation may obviate some of the problems of administering virus alone, including rapid loss to the liver and lack of penetration into tissue.12 Targeting transduction to circulating monocytes may also be possible by coating the viral particles with sugars that bind to specific receptors on these cells.37 This would prevent loss of the adenovirus to the liver after systemic administration.
###end p 68
###begin p 69
###xml 85 87 85 87 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">38</sup>
###xml 85 87 85 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib38" ref-type="bibr"><sup>38</sup></xref>
One study suggested that up-regulation of macrophage uPA might enhance atherogenesis,38 but that study was done in animals whose macrophages constitutively over-expressed uPA. The method of uPA up-regulation used in this study is transient (approximately 15 days) and is therefore unlikely to cause long-term problems.
###end p 69
###begin p 70
###xml 50 51 50 51 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</label>
###xml 51 148 51 148 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="71">the time of delivery of the fibrinolytically overactive macrophages to the thrombus is important;</p>
###xml 50 148 50 148 <list-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><label>1</label><p textid="71">the time of delivery of the fibrinolytically overactive macrophages to the thrombus is important;</p></list-item>
###xml 148 149 148 149 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</label>
###xml 149 255 149 255 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="72">injected monocytes enhance resolution directly or indirectly by promoting endogenous monocyte recruitment;</p>
###xml 148 255 148 255 <list-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><label>2</label><p textid="72">injected monocytes enhance resolution directly or indirectly by promoting endogenous monocyte recruitment;</p></list-item>
###xml 255 256 255 256 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</label>
###xml 256 427 256 427 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="73">the effect of concomitantly up-regulating other factors, known to increase uPA activity, such as its substrate plasminogen could enhance their ability to resolve thrombus;</p>
###xml 255 427 255 427 <list-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><label>3</label><p textid="73">the effect of concomitantly up-regulating other factors, known to increase uPA activity, such as its substrate plasminogen could enhance their ability to resolve thrombus;</p></list-item>
###xml 427 428 427 428 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</label>
###xml 428 560 428 560 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="74">the use of more powerful viral promoters that generate higher and more sustained levels of uPA production have greater efficacy; and</p>
###xml 427 560 427 560 <list-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><label>4</label><p textid="74">the use of more powerful viral promoters that generate higher and more sustained levels of uPA production have greater efficacy; and</p></list-item>
###xml 560 561 560 561 <label xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</label>
###xml 561 631 561 631 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="75">it is possible to reduce loss of injected cells to other tissue sinks.</p>
###xml 560 631 560 631 <list-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><label>5</label><p textid="75">it is possible to reduce loss of injected cells to other tissue sinks.</p></list-item>
###xml 50 631 50 631 <list xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" list-type="simple"><list-item><label>1</label><p textid="71">the time of delivery of the fibrinolytically overactive macrophages to the thrombus is important;</p></list-item><list-item><label>2</label><p textid="72">injected monocytes enhance resolution directly or indirectly by promoting endogenous monocyte recruitment;</p></list-item><list-item><label>3</label><p textid="73">the effect of concomitantly up-regulating other factors, known to increase uPA activity, such as its substrate plasminogen could enhance their ability to resolve thrombus;</p></list-item><list-item><label>4</label><p textid="74">the use of more powerful viral promoters that generate higher and more sustained levels of uPA production have greater efficacy; and</p></list-item><list-item><label>5</label><p textid="75">it is possible to reduce loss of injected cells to other tissue sinks.</p></list-item></list>
Further studies are required to determine whether:1the time of delivery of the fibrinolytically overactive macrophages to the thrombus is important;2injected monocytes enhance resolution directly or indirectly by promoting endogenous monocyte recruitment;3the effect of concomitantly up-regulating other factors, known to increase uPA activity, such as its substrate plasminogen could enhance their ability to resolve thrombus;4the use of more powerful viral promoters that generate higher and more sustained levels of uPA production have greater efficacy; and5it is possible to reduce loss of injected cells to other tissue sinks.
###end p 70
###begin p 71
the time of delivery of the fibrinolytically overactive macrophages to the thrombus is important;
###end p 71
###begin p 72
injected monocytes enhance resolution directly or indirectly by promoting endogenous monocyte recruitment;
###end p 72
###begin p 73
the effect of concomitantly up-regulating other factors, known to increase uPA activity, such as its substrate plasminogen could enhance their ability to resolve thrombus;
###end p 73
###begin p 74
the use of more powerful viral promoters that generate higher and more sustained levels of uPA production have greater efficacy; and
###end p 74
###begin p 75
it is possible to reduce loss of injected cells to other tissue sinks.
###end p 75
###begin title 76
Conclusions
###end title 76
###begin p 77
###xml 205 209 205 209 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">7,31</sup>
###xml 205 209 205 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib7 bib31" ref-type="bibr"><sup>7,31</sup></xref>
###xml 254 256 254 256 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">11</sup>
###xml 254 256 254 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib11" ref-type="bibr"><sup>11</sup></xref>
###xml 295 297 295 297 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">23</sup>
###xml 295 297 295 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib23" ref-type="bibr"><sup>23</sup></xref>
This study provides evidence that up-regulating monocyte uPA enhances thrombus resolution. Our previous studies have shown that thrombus resolution can be enhanced through the direct injection of monocytes7,31 or adenovirus constructs over-expressing uPA11 or vascular endothelial growth factor.23 Increasing the circulating concentrations of monocyte chemotaxins and angiogenic agents may be counterproductive because they could reduce recruitment of monocytes and other cells important in thrombus organization by overwhelming chemotactic gradients. Monocytes could act as vectors that allow more specific targeting of the thrombus. The proteins that are up-regulated and the means by which this is achieved would obviously require refinement.
###end p 77
###begin p 78
###xml 237 239 237 239 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">39</sup>
###xml 237 239 237 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib39" ref-type="bibr"><sup>39</sup></xref>
###xml 356 358 356 358 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">40</sup>
###xml 356 358 356 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" rid="bib40" ref-type="bibr"><sup>40</sup></xref>
There is also increasing evidence to suggest that macrophages display phenotypic heterogeneity, with at least two subtypes that are associated with either proinflammatory activity (M1-type macrophages) or remodelling (M2-type) processes.39 All monocytes isolated and used in this study were pretreated with MCSF, which is thought to induce an M2 phenotype.40 We do not know, however, whether viral transduction or the thrombus milieu had an effect on this.
###end p 78
###begin p 79
The development of any treatment that uses exogenous altered cells, promotes their number through bone marrow stimulation, or alters the activity of endogenous circulating cells will rely on a better understanding of how these phenotypes contribute to thrombus resolution.
###end p 79
###begin title 80
Author contributions
###end title 80
###begin p 81
###xml 0 41 0 41 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="82">Conception and design: JH, JG, MB, KB, AS</p>
###xml 0 41 0 41 <list-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="82">Conception and design: JH, JG, MB, KB, AS</p></list-item>
###xml 41 84 41 84 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="83">Analysis and interpretation: JH, JG, MB, AS</p>
###xml 41 84 41 84 <list-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="83">Analysis and interpretation: JH, JG, MB, AS</p></list-item>
###xml 84 115 84 115 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="84">Data collection: JH, JG, MB, CM</p>
###xml 84 115 84 115 <list-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="84">Data collection: JH, JG, MB, CM</p></list-item>
###xml 115 146 115 146 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="85">Writing the article: JH, JG, AS</p>
###xml 115 146 115 146 <list-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="85">Writing the article: JH, JG, AS</p></list-item>
###xml 146 194 146 194 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="86">Critical revision of the article: JH, JG, TS, KB</p>
###xml 146 194 146 194 <list-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="86">Critical revision of the article: JH, JG, TS, KB</p></list-item>
###xml 194 235 194 235 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="87">Final approval of the article: JH, TS, AS</p>
###xml 194 235 194 235 <list-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="87">Final approval of the article: JH, TS, AS</p></list-item>
###xml 235 271 235 271 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="88">Statistical analysis: JH, JG, CM, AS</p>
###xml 235 271 235 271 <list-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="88">Statistical analysis: JH, JG, CM, AS</p></list-item>
###xml 271 299 271 299 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="89">Obtained funding: JH, JG, AS</p>
###xml 271 299 271 299 <list-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="89">Obtained funding: JH, JG, AS</p></list-item>
###xml 299 325 299 325 <p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" textid="90">Overall responsibility: AS</p>
###xml 299 325 299 325 <list-item xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><p textid="90">Overall responsibility: AS</p></list-item>
###xml 0 325 0 325 <list xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" list-type="simple"><list-item><p textid="82">Conception and design: JH, JG, MB, KB, AS</p></list-item><list-item><p textid="83">Analysis and interpretation: JH, JG, MB, AS</p></list-item><list-item><p textid="84">Data collection: JH, JG, MB, CM</p></list-item><list-item><p textid="85">Writing the article: JH, JG, AS</p></list-item><list-item><p textid="86">Critical revision of the article: JH, JG, TS, KB</p></list-item><list-item><p textid="87">Final approval of the article: JH, TS, AS</p></list-item><list-item><p textid="88">Statistical analysis: JH, JG, CM, AS</p></list-item><list-item><p textid="89">Obtained funding: JH, JG, AS</p></list-item><list-item><p textid="90">Overall responsibility: AS</p></list-item></list>
Conception and design: JH, JG, MB, KB, ASAnalysis and interpretation: JH, JG, MB, ASData collection: JH, JG, MB, CMWriting the article: JH, JG, ASCritical revision of the article: JH, JG, TS, KBFinal approval of the article: JH, TS, ASStatistical analysis: JH, JG, CM, ASObtained funding: JH, JG, ASOverall responsibility: AS
###end p 81
###begin p 82
Conception and design: JH, JG, MB, KB, AS
###end p 82
###begin p 83
Analysis and interpretation: JH, JG, MB, AS
###end p 83
###begin p 84
Data collection: JH, JG, MB, CM
###end p 84
###begin p 85
Writing the article: JH, JG, AS
###end p 85
###begin p 86
Critical revision of the article: JH, JG, TS, KB
###end p 86
###begin p 87
Final approval of the article: JH, TS, AS
###end p 87
###begin p 88
Statistical analysis: JH, JG, CM, AS
###end p 88
###begin p 89
Obtained funding: JH, JG, AS
###end p 89
###begin p 90
Overall responsibility: AS
###end p 90
###begin p 91
This project was supported by the British Heart Foundation project grant PG/02/012/13507 to Dr Humphries.
###end p 91
###begin p 92
Competition of interest: none.
###end p 92
###begin title 93
References
###end title 93
###begin article-title 94
###xml 23 27 <span type="species:ncbi:9913">calf</span>
The natural history of calf vein thrombosis: lysis of thrombi and development of reflux
###end article-title 94
###begin article-title 95
Determinants of chronic venous disease after acute deep venous thrombosis
###end article-title 95
###begin article-title 96
The treatment of deep venous thrombosis, including the newer agents
###end article-title 96
###begin article-title 97
Catheter-directed thrombolysis for lower extremity deep vein thrombosis
###end article-title 97
###begin article-title 98
The maturation and canalisation of thrombi
###end article-title 98
###begin article-title 99
The tissue plasminogen activator and urokinase response in vivo during natural resolution of venous thrombus
###end article-title 99
###begin article-title 100
Recruitment of labelled monocytes by experimental venous thrombi
###end article-title 100
###begin article-title 101
###xml 79 84 <span type="species:ncbi:10090">mouse</span>
Plasminogen activators in tissue remodeling and invasion: mRNA localization in mouse ovaries and implanting embryos
###end article-title 101
###begin article-title 102
###xml 54 59 <span type="species:ncbi:9606">human</span>
Plasminogen activator-specific inhibitors produced by human monocytes/macrophages
###end article-title 102
###begin article-title 103
###xml 85 89 <span type="species:ncbi:10090">mice</span>
Failure of thrombus to resolve in urokinase-type plasminogen activator gene-knockout mice: rescue by normal bone marrow-derived cells
###end article-title 103
###begin article-title 104
Adenoviral urokinase-type plasminogen activator (uPA) gene transfer enhances venous thrombus resolution
###end article-title 104
###begin article-title 105
Interactions of adenovirus vectors with blood: implications for intravascular gene therapy applications
###end article-title 105
###begin article-title 106
Participation of urokinase-type plasminogen activator receptor in the clearance of fibrin from the lung
###end article-title 106
###begin article-title 107
###xml 58 63 <span type="species:ncbi:9606">human</span>
A quick, easy and inexpensive method for the isolation of human peripheral blood monocytes
###end article-title 107
###begin article-title 108
Efficient adenoviral infection with IkappaB alpha reveals that macrophage tumor necrosis factor alpha production in rheumatoid arthritis is NF-kappaB dependent
###end article-title 108
###begin article-title 109
Comparative study of different urokinase preparations
###end article-title 109
###begin article-title 110
An enzyme-linked immunosorbent assay for urokinase-type plasminogen activator (u-PA) and mutants and chimeras containing the serine protease domain of u-PA
###end article-title 110
###begin article-title 111
###xml 30 36 <span type="species:ncbi:9986">rabbit</span>
###xml 108 114 <span type="species:ncbi:9986">rabbit</span>
Immunological quantitation of rabbit plasminogen activator inhibitor-1 in biological samples: evidence that rabbit platelets do not contain PAI-1
###end article-title 111
###begin article-title 112
Identification of potentially effective antisense oligodeoxyribonucleotide (ODN) sequences for inhibiting plasminogen activator inhibitor-2 (PAI-2) production by monocytes
###end article-title 112
###begin article-title 113
Migration of mononuclear cells in the modified Boyden chamber as evaluated by DNA quantification and flow cytometry
###end article-title 113
###begin article-title 114
Vascular endothelial growth factor enhances venous thrombus recanalisation and organisation
###end article-title 114
###begin article-title 115
Fluorescent cell labelling for in vivo and in vitro cell tracking
###end article-title 115
###begin article-title 116
Adenovirus-mediated VEGF gene therapy enhances venous thrombus recanalization and resolution
###end article-title 116
###begin article-title 117
Dimerization controls the lipid raft partitioning of uPAR/CD87 and regulates its biological functions
###end article-title 117
###begin article-title 118
Recycling of the urokinase receptor upon internalization of the uPA:serpin complexes
###end article-title 118
###begin article-title 119
Modulating the fibrinolytic system of peripheral blood mononuclear cells with adenovirus
###end article-title 119
###begin article-title 120
###xml 43 48 <span type="species:ncbi:9606">human</span>
The release of inflammatory cytokines from human peripheral blood mononuclear cells in vitro following exposure to adenovirus variants and capsid
###end article-title 120
###begin article-title 121
###xml 56 59 <span type="species:ncbi:10116">rat</span>
Neutropenia impairs venous thrombosis resolution in the rat
###end article-title 121
###begin article-title 122
###xml 82 87 <span type="species:ncbi:9606">human</span>
Involvement of the mural thrombus as a site of protease release and activation in human aortic aneurysms
###end article-title 122
###begin article-title 123
Polymorphonuclear leucocytes have two opposing roles in fibrinolysis
###end article-title 123
###begin article-title 124
Monocyte recruitment in venous thrombus resolution
###end article-title 124
###begin article-title 125
Monocyte chemotactic protein-1 (MCP-1) accelerates the organization and resolution of venous thrombi
###end article-title 125
###begin article-title 126
###xml 39 44 <span type="species:ncbi:9606">human</span>
The urokinase receptor is required for human monocyte chemotaxis in vitro
###end article-title 126
###begin article-title 127
Proteolysis, cell adhesion, chemotaxis, and invasiveness are regulated by the u-PA-u-PAR-PAI-1 system
###end article-title 127
###begin article-title 128
Regulation and interactions in the activation of cell-associated plasminogen
###end article-title 128
###begin article-title 129
Adoptive transfer of tumor cytotoxic macrophages generated in vitro from circulating blood monocytes: a new approach to cancer immunotherapy
###end article-title 129
###begin article-title 130
Glycoviruses: chemical glycosylation retargets adenoviral gene transfer
###end article-title 130
###begin article-title 131
Macrophage-targeted overexpression of urokinase causes accelerated atherosclerosis, coronary artery occlusions, and premature death
###end article-title 131
###begin article-title 132
Macrophage heterogeneity and tissue lipids
###end article-title 132
###begin article-title 133
###xml 33 38 <span type="species:ncbi:9606">human</span>
Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression
###end article-title 133
###begin p 134
###xml 54 58 54 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(ad)</italic>
###xml 107 115 107 115 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(ad-uPA)</italic>
###xml 208 212 208 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bars</italic>
###xml 451 452 451 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Migration of MM6 cells treated with either adenovirus (ad) expressing urokinase-type plasminogen activator (ad-uPA) or ad-blank across a fibrin matrix (n = 5). Each experiment was performed in quintuplicate (bars represent means). Transfection with ad-uPA resulted in a more rapid migration of MM6 cells across fibrin-coated filters (11% [standard error of the mean, 1.4%]) compared with ad-blank-treated cells (5% [standard error of the mean, 0.6%], P = .005).
###end p 134
###begin p 135
###xml 62 66 62 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(ad)</italic>
###xml 115 123 115 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(ad-uPA)</italic>
###xml 458 459 458 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Migration of primary monocytes treated with either adenovirus (ad) expressing urokinase-type plasminogen activator (ad-uPA) or ad-blank across a fibrin matrix (n = 10). Each experiment was performed in triplicate (Bars represent means). Treatment with ad-uPA also resulted in the accelerated movement of cells across fibrin-coated filters (70% [standard error of the mean, 8.9%]) compared with ad-blank-treated cells (54% [standard error of the mean, 9.8%], P = .03).
###end p 135
###begin p 136
###xml 64 65 64 65 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 82 99 82 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">blue fluorescence</italic>
###xml 101 102 101 102 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 158 174 158 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">red fluorescence</italic>
###xml 176 177 176 177 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 199 217 199 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">green fluorescence</italic>
###xml 219 220 219 220 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 133 138 <span type="species:ncbi:9606">human</span>
###xml 256 261 <span type="species:ncbi:9606">human</span>
Recruitment of systemically injected monocytes in the thrombus. A, Nuclear stain, blue fluorescence. B, Immunohistochemical staining human leukocyte antigen, red fluorescence. C, PKH2-labeled cells, green fluorescence. D, Composite staining of PKH-labeled human monocytes with antihuman leukocyte antigen (original magnification x400).
###end p 136
###begin p 137
###xml 36 40 36 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">(ad)</italic>
###xml 79 82 79 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">uPA</italic>
###xml 338 339 338 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 440 441 440 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 477 481 477 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bars</italic>
###xml 97 102 <span type="species:ncbi:9606">human</span>
Intravenous injection of adenovirus (ad) urokinase-type plasminogen activator (uPA) up-regulated human blood monocyte-derived macrophages (HBMMs) reduced thrombus weight at 7 days by approximately 20% (9.0 mg [standard error of the mean] 0.52 mg) compared with either ad-blank-treated HBMMs (11.0 mg [standard error of the mean, 0.74 mg] P = .038) or control animals injected with carrier alone (13.3 mg [standard error of the mean, 1.08], P = .0028). N = 8 in each group. The bars represent means.
###end p 137
###begin p 138
###xml 48 53 <span type="species:ncbi:9606">human</span>
Expression of fibrinolytic mediators by primary human blood-derived monocyte/macrophages transfected with ad-uPA and ad-blank and baseline cells treated with carrier alone
###end p 138
###begin p 139
###xml 0 2 0 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ad</italic>
###xml 16 18 16 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NS</italic>
###xml 37 40 37 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PAI</italic>
###xml 77 80 77 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">uPA</italic>
###xml 120 124 120 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">uPAR</italic>
Ad, Adenovirus; NS, not significant; PAI, plasminogen activator inhibitor-1; uPA, urokinase-type plasminogen activator; uPAR, urokinase plasminogen activator receptor.
###end p 139
###begin p 140
Data are expressed as mean (standard error of the mean) of 12 healthy individuals.
###end p 140
###begin p 141
###xml 35 40 <span type="species:ncbi:9606">human</span>
Expression of cytokines by primary human blood-derived monocytes/macrophages transfected with ad-uPA, ad-blank, and baseline cells treated with carrier alone
###end p 141
###begin p 142
###xml 0 2 0 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ad</italic>
###xml 16 22 16 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GM-CSF</italic>
###xml 74 76 74 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL</italic>
###xml 91 94 91 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">INF</italic>
###xml 108 114 108 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RANTES</italic>
###xml 180 183 180 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">uPA</italic>
Ad, Adenovirus; GM-CSF, granulocyte macrophage-colony stimulating factor; IL, interleukin; INF, interferon; RANTES, regulated upon activation normal T-cell expressed and secreted; uPA, urokinase-type plasminogen activator.
###end p 142
###begin p 143
Data are expressed as mean (standard error of the mean) of 12 healthy individuals.
###end p 143

